California Health and Safety Code Section 382.7 criminalizes knowingly prescribing, dispensing, administering, or furnishing liquid silicone for injection into human breasts. This statute addresses serious public health concerns about unlicensed cosmetic procedures and dangerous body modification practices, yet its application can ensnare medical professionals, aesthetics practitioners, and individuals who believed they were providing legitimate services.
Understanding the knowledge requirement, the specific prohibited conduct, and available defenses becomes essential for anyone facing these charges.
The Medical Context Behind Section 382.7
Section 382.7 emerged from California's response to a persistent underground market for liquid silicone breast injections that has caused devastating health consequences for countless individuals. Understanding the medical and social context surrounding this prohibition helps explain why the legislature criminalized this specific practice and informs defense strategies.
Liquid injectable silicone differs fundamentally from FDA approved silicone gel breast implants used in legitimate plastic surgery. While encapsulated silicone gel implants undergo rigorous testing and regulatory approval, liquid silicone injected directly into breast tissue lacks any FDA approval for this use. Industrial grade silicone, automotive products, and other non medical silicone substances are sometimes used by unscrupulous practitioners, creating severe health risks.
Medical complications from liquid silicone injections include granulomas, chronic inflammation, infection, silicone migration to other body parts, tissue necrosis, disfigurement, chronic pain, and life threatening systemic reactions. Once liquid silicone enters tissue, it cannot be completely removed, making complications permanent and often progressive. These serious health consequences motivated California's decision to criminalize the practice.
The underground market for these procedures targets vulnerable populations including transgender women seeking breast augmentation, economically disadvantaged individuals who cannot afford legitimate plastic surgery, and immigrants from countries where liquid silicone injections are more common. Unlicensed practitioners often operate in private homes, hotel rooms, or informal clinics, using non sterile equipment and industrial grade materials. This combination of dangerous substances and unsanitary conditions creates catastrophic health outcomes.
Law enforcement emphasis on prosecuting liquid silicone injection providers reflects public health priorities. District attorneys and medical licensing boards coordinate enforcement efforts targeting both licensed medical professionals who engage in this prohibited practice and unlicensed individuals who hold themselves out as qualified to perform cosmetic procedures. These investigations often follow medical emergencies when victims seek hospital treatment for complications.
Understanding the Prohibited Conduct
Section 382.7 criminalizes four distinct categories of conduct involving liquid silicone and breast injections. Understanding each prohibited action helps defendants and their attorneys identify exactly what prosecutors must prove and where defenses may exist.
Prescribing liquid silicone for breast injection involves licensed medical professionals writing prescriptions or orders authorizing acquisition of liquid silicone for this purpose. Physicians who provide patients with prescriptions for injectable silicone, who write orders directing pharmacies or suppliers to provide liquid silicone, or who create treatment plans calling for silicone breast injections engage in prohibited prescribing.
This provision ensures that medical licensing authority cannot be exploited to legitimize dangerous procedures.
Dispensing encompasses providing liquid silicone substances to others for breast injection purposes. This includes pharmacists who fill prescriptions for injectable silicone knowing the intended use, suppliers who provide liquid silicone to practitioners or patients, and anyone who transfers possession of silicone substances intended for breast injection. The dispensing prohibition targets those who facilitate the procedures even if they do not personally perform injections.
Administering represents the most direct form of prohibited conduct, involving actually performing liquid silicone breast injections. Practitioners who insert needles or syringes into breast tissue and inject liquid silicone engage in administration regardless of whether they hold medical licenses. This provision captures the actual performance of dangerous procedures that directly harm victims.
Furnishing covers making liquid silicone available for breast injection without necessarily transferring possession. Someone who allows others to access liquid silicone supplies, who makes injection equipment available, or who provides facilities where liquid silicone breast injections occur may engage in furnishing. This broad term ensures that various forms of participation in the prohibited practice create criminal liability.
The specific purpose requirement means that liquid silicone must be intended "for the purpose of injection into a human breast or mammary." This language creates an intent element that becomes crucial for defense. Liquid silicone has legitimate medical uses in certain contexts, and simply possessing or transferring silicone does not violate Section 382.7 unless the specific purpose involves breast injection.
The Knowledge Requirement and Defense Implications
Section 382.7 requires that defendants "knowingly" engage in prohibited conduct, creating a mens rea element that prosecutors must prove beyond a reasonable doubt. This knowledge requirement provides the primary defense opportunity in many prosecutions and distinguishes between criminal conduct and innocent activity.
Knowledge of substance identity means defendants must have known they were dealing with liquid silicone rather than other substances. If someone prescribed, dispensed, administered, or furnished what they genuinely believed to be FDA approved dermal fillers, legitimate medications, or other authorized substances, they lacked the requisite knowledge.
Defense attorneys present evidence about what defendants believed they were handling, what representations were made about substance identity, and whether circumstances gave defendants reason to know the true nature of materials.
Knowledge of intended use requires proof that defendants knew the liquid silicone was intended specifically for breast injection. Someone who sold industrial silicone believing it would be used for manufacturing purposes, or who dispensed medical grade silicone thinking it was for approved medical procedures, lacked knowledge of the prohibited breast injection purpose.
Evidence about representations made by purchasers, contexts suggesting different uses, and absence of circumstances indicating breast injection intent supports these defenses.
Willful blindness or deliberate ignorance can substitute for actual knowledge when defendants purposely avoid learning what they suspect to be true. Courts may find knowledge satisfied when evidence shows defendants deliberately avoided confirming their suspicions about substance identity or intended use. However, mere negligence or failure to investigate does not constitute willful blindness. Defense attorneys distinguish between intentional avoidance and innocent failure to discover facts.
The timing of when knowledge formed affects liability. Someone who initially prescribed or furnished silicone for legitimate purposes but later learned it was being used for breast injection does not retroactively become guilty of earlier conduct. Criminal liability attaches only to conduct undertaken with the required knowledge at the time of the action.
Reasonable mistake of fact provides a defense when defendants genuinely believed circumstances that, if true, would make their conduct lawful. A physician who reasonably believed they were administering FDA approved breast augmentation products rather than prohibited liquid silicone, or who thought they were treating medical conditions rather than performing cosmetic enhancement, may establish mistake of fact defenses. The reasonableness of the mistake determines whether this defense succeeds.
Distinguishing Legitimate from Prohibited Procedures
Understanding what breast procedures remain legal helps defendants establish that their conduct fell outside Section 382.7's prohibition. Several legitimate medical and cosmetic procedures involve silicone in contexts distinct from prohibited liquid silicone injection.
FDA approved silicone gel breast implants represent the legitimate alternative to liquid silicone injection. Board certified plastic surgeons performing breast augmentation using encapsulated silicone implants through proper surgical procedures engage in legal, regulated medical practice. The crucial distinction is that approved implants involve silicone gel contained within a shell and surgically placed, not liquid silicone directly injected into tissue.
Approved dermal fillers for facial enhancement or body contouring use hyaluronic acid, calcium hydroxylapatite, or other substances specifically approved for injection purposes. These products undergo rigorous FDA testing and approval processes. Medical professionals who perform injection procedures using approved dermal fillers do not violate Section 382.7 even if some procedures involve areas near breast tissue, provided they use approved substances according to FDA approved indications.
Medical procedures using silicone in other contexts remain lawful when performed for legitimate medical purposes using approved products. Certain ophthalmic procedures, some dermatological treatments, and other medical applications may involve silicone substances in forms and contexts distinct from prohibited breast injection.
Establishing that procedures involved legitimate rather than prohibited practices requires detailed evidence about what substances were used, what procedures were performed, what products were FDA approved, and how practices conformed to medical standards.
Defense attorneys obtain product packaging, FDA approval documentation, medical literature about approved uses, and expert testimony from qualified medical professionals explaining the distinctions.
Common Scenarios Leading to Section 382.7 Charges
Understanding typical circumstances that result in charges under this statute helps defendants recognize patterns and often reveals specific defense strategies applicable to their situations.
Underground cosmetic practitioners operating without proper licenses or using prohibited substances generate the majority of prosecutions. These cases often involve individuals who market breast enhancement services through word of mouth or social media, perform procedures in residential settings or hotel rooms, and use industrial grade silicone or other inappropriate materials. Victims who suffer complications and seek medical treatment trigger investigations leading to criminal charges.
Licensed medical professionals who deviate from proper standards sometimes face Section 382.7 charges when investigations reveal they performed liquid silicone injections. Physicians, nurses, or other licensed practitioners who should know better but engage in these prohibited procedures face both criminal prosecution and medical licensing board actions. These cases often involve practitioners who catered to underserved populations or who sought additional income through cash based cosmetic services.
Product misrepresentation cases occur when defendants claim to use approved substances but actually inject liquid silicone. Practitioners may advertise legitimate dermal filler procedures while secretly using cheaper liquid silicone to increase profit margins. When product testing or patient medical records reveal the deception, criminal charges follow. These cases involve both Section 382.7 violations and fraud related offenses.
Supplier prosecution happens when investigations trace liquid silicone back to sources who provided materials to injection practitioners. Manufacturers, distributors, or sellers of industrial silicone or non medical grade products who knew or should have known their products would be used for prohibited breast injections face charges under the dispensing or furnishing prongs of Section 382.7.
Cross border situations involve practitioners or patients who travel between jurisdictions where different legal standards apply. Cases sometimes arise when individuals from countries where liquid silicone injection is legal come to California and continue practices that violate Section 382.7. Cultural differences and misunderstanding of California law sometimes contribute to these violations.
Professional Licensing Consequences
Section 382.7 violations trigger devastating professional consequences for licensed medical practitioners beyond direct criminal penalties. Understanding these collateral consequences helps defendants appreciate the full stakes and motivates comprehensive defense strategies.
Medical Board of California investigations run parallel to criminal prosecutions when licensed physicians are charged. The Medical Board pursues license discipline independently of criminal proceedings, meaning physicians face dual jeopardy from both criminal courts and administrative licensing proceedings. Conviction under Section 382.7 typically results in license revocation, effectively ending medical careers.
Nursing board actions threaten registered nurses and nurse practitioners charged under Section 382.7. The Board of Registered Nursing takes violations of health and safety statutes seriously, particularly those involving dangerous procedures and patient harm. License suspension or revocation proceedings move forward regardless of criminal case outcomes, and even dismissals of criminal charges may not prevent licensing discipline.
Other professional licenses including those for aestheticians, cosmetologists, and other beauty industry practitioners face discipline for Section 382.7 violations. While these practitioners should not be performing injectable procedures at all, those who engage in liquid silicone breast injections face both criminal charges and license revocation proceedings before their respective licensing boards.
Hospital privileges and medical staff appointments are immediately suspended when Section 382.7 charges are filed. Healthcare facilities cannot risk liability by allowing practitioners accused of dangerous illegal procedures to continue treating patients. Loss of hospital privileges prevents physicians from performing surgeries, admitting patients, or practicing in institutional settings even if criminal charges are ultimately dismissed.
Malpractice insurance coverage may be denied or canceled when insurers learn about Section 382.7 charges. Professional liability policies typically exclude coverage for illegal acts or intentional misconduct. Practitioners facing charges may find themselves uninsured just when they most need legal defense resources and potential indemnity coverage.
Professional reputation damage proves impossible to fully repair even when charges are dismissed or defendants are acquitted. News coverage of arrests, online records of charges, and professional community awareness of allegations permanently taint reputations. Patients lose trust, referral sources dry up, and career advancement opportunities disappear.
Victim Cooperation and Witness Issues
Section 382.7 prosecutions often depend heavily on testimony from individuals who received liquid silicone injections. These cases present unique witness issues that create both challenges and opportunities for defense.
Reluctant victims sometimes refuse to cooperate with prosecution because they fear immigration consequences, embarrassment about seeking cosmetic procedures, or loyalty to defendants who they believe tried to help them.
This reluctance can undermine prosecution cases when victims refuse to testify, provide inconsistent statements, or minimize the nature of procedures they received. Defense attorneys explore these witness issues to challenge prosecution evidence.
Medical records documenting complications provide objective evidence that may substitute for victim testimony. Hospital emergency room visits, treatment for infections or granulomas, imaging studies showing silicone deposits, and specialist evaluations create documentation of prohibited procedures even if victims will not testify. Defense strategies must address this documentary evidence rather than relying solely on victim non cooperation.
Expert medical testimony about substance identification becomes crucial when victims cannot or will not definitively identify what was injected. Radiologists, pathologists, and other specialists can testify about imaging findings, biopsy results, and clinical presentations consistent with liquid silicone injection. Defense experts challenge these medical opinions by presenting alternative explanations for clinical findings.
Credibility challenges arise when victims have motives to fabricate or exaggerate claims. Victims seeking financial compensation through civil litigation, attempting to avoid immigration consequences by claiming victim status, or retaliating against defendants for reasons unrelated to procedures may provide unreliable testimony. Defense attorneys investigate victim motives and prior statements for inconsistencies.
Multiple victim cases create stronger prosecution evidence through pattern testimony. When several individuals describe similar procedures, facilities, substances, and techniques, this corroboration makes any single victim's reliability less critical. Defense strategies must address the cumulative weight of multiple victim accounts rather than focusing solely on individual witness credibility.
Penalties and Sentencing Considerations
Section 382.7 classifies violations as misdemeanors, which limits maximum penalties but still creates serious consequences for convicted defendants. Understanding the sentencing framework helps defendants and attorneys evaluate case resolution options.
Maximum penalties for misdemeanors in California include up to six months in county jail and fines up to $1,000. Courts also impose probation conditions that may include community service, restitution to victims, prohibition on practicing any healthcare or cosmetic services, and other restrictions. While less severe than felony penalties, these consequences still create significant hardship.
Aggravating factors that increase sentence severity include multiple victims, serious injuries resulting from procedures, operation of commercial injection businesses, use of unsanitary conditions or equipment, targeting vulnerable populations, and prior violations. Prosecutors emphasize these factors to argue for maximum sentences including jail time.
Mitigating factors that reduce sentence severity include absence of serious victim injuries, first time offenses, genuine belief in procedure legitimacy, cooperation with authorities, acceptance of responsibility, and evidence of remorse. Defense attorneys present comprehensive mitigation packages arguing for lenient sentences focused on probation rather than incarceration.
Restitution orders require defendants to compensate victims for medical expenses, corrective procedures, pain and suffering, and other damages resulting from liquid silicone injections.
These financial obligations can reach tens or hundreds of thousands of dollars when victims require extensive medical treatment or corrective surgery. Restitution obligations survive bankruptcy and continue until fully paid.
Probation conditions are tailored to prevent recurrence and ensure public safety. Courts may prohibit defendants from practicing healthcare or cosmetic services, require completion of education about proper medical standards, mandate community service in healthcare settings, and impose other conditions designed to prevent future violations.
Why Specialized Defense Counsel Is Essential
Section 382.7 cases involve unique medical, scientific, and professional licensing issues that require attorneys with specific expertise beyond general criminal defense practice.
Medical and scientific knowledge helps attorneys understand cosmetic procedures, distinguish approved from prohibited substances, evaluate medical evidence about complications, and effectively cross examine medical expert witnesses. This technical literacy proves essential for challenging prosecution evidence.
Professional licensing experience allows attorneys to coordinate criminal defense with parallel licensing proceedings, develop strategies that address both criminal and administrative consequences, and negotiate resolutions that minimize career damage.
For comprehensive guidance on defending against California illegal medical procedure charges, consulting with an experienced criminal defense attorney protects your freedom, your professional license, and your future.
Call us at (888) 928-1609 or use our email form.